Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
11.30
+0.26 (2.36%)
At close: Sep 28, 2026, 4:00 PM EDT
11.41
+0.11 (0.97%)
Pre-market: Sep 29, 2026, 8:09 AM EDT
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $671.04 million as of September 28, 2026. Its market cap has increased by 22.36% in one year.
Market Cap
671.04M
Enterprise Value
450.96M
1-Year Change
22.36%
Ranking
Category
Stock Price
$11.30
ChartMarket Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $671.04M, an increase of 386.96%. That is a compound annual growth rate of 14.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 671.04M | 33.04% |
| Dec 31, 2025 | 504.40M | 13.30% |
| Dec 31, 2024 | 445.20M | 87.69% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
| Apr 16, 2015 | 137.80M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 704.38M |
| Verastem | 703.68M |
| DBV Technologies | 697.14M |
| OmniAb | 689.15M |
| MiMedx Group | 682.89M |
| BlossomHill Therapeutics | 678.29M |
| Nuvectis Pharma | 678.02M |
| Silence Therapeutics | 674.34M |